We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ADMA market cap is 3.87B. The company's latest EPS is USD -0.1195 and P/E is -136.99.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 67.27M | 73.9M | 81.88M | 107.19M | 119.84M |
| Operating Income | 8.69M | 14.23M | 21.82M | 39.2M | 39.64M |
| Net Income | 2.57M | -17.65M | 17.81M | 32.06M | 35.91M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 29.35M | 42.22M | 80.94M | 154.08M | 258.22M |
| Operating Income | -41.43M | -64.91M | -58.37M | -39.37M | 21.63M |
| Net Income | -48.28M | -75.75M | -71.65M | -65.9M | -28.24M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 349M | 329.18M | 350.88M | 376.4M | 390.62M |
| Total Liabilities | 197.56M | 193.98M | 197.17M | 188.13M | 158.73M |
| Total Equity | 151.44M | 135.21M | 153.71M | 188.27M | 231.89M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 127.09M | 207.67M | 276.25M | 348.46M | 329.18M |
| Total Liabilities | 100.9M | 119.42M | 135.08M | 196.49M | 193.98M |
| Total Equity | 26.19M | 88.25M | 141.17M | 151.97M | 135.21M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.8M | 8.8M | -2.22M | 43.43M | 68.46M |
| Investing | -3.57M | -4.98M | -2.36M | -4.73M | -5.83M |
| Financing | 5k | -38.99M | -1.45M | -1.81M | -27.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -76.19M | -102M | -112.37M | -59.51M | 8.8M |
| Investing | -3.81M | -12.73M | -13.51M | -13.91M | -4.98M |
| Financing | 80M | 143.9M | 121.05M | 108.85M | -38.99M |
| Market Cap | 3.87B |
| Price to Earnings Ratio | -136.99 |
| Price to Sales Ratio | 14.99 |
| Price to Cash Ratio | 75.37 |
| Price to Book Ratio | 28.62 |
| Dividend Yield | - |
| Shares Outstanding | 236.39M |
| Average Volume (1 week) | 2.37M |
| Average Volume (1 Month) | 2.53M |
| 52 Week Change | 209.06% |
| 52 Week High | 23.64 |
| 52 Week Low | 5.02 |
| Spread (Intraday) | 0.52 (3.12%) |
| Company Name | Adma Biologics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.admabiologics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
